Childhood Cancer Incidence, New York City, 2015-2019
Source: New York State Cancer Registry
| Site of Cancer | Ages 0-4 | Ages 5-9 | Ages 10-14 | Ages 15-19 | Combined Ages 0-14 | Combined Ages 0-19 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | 95% CI | Avg Annual Cases | Rate per 1,000,000 | 95% CI | |
| All Invasive Malignant Tumors | 135.2 | 247.8 | 70.6 | 145.4 | 90.2 | 199.0 | 135.0 | 300.5 | 296.0 | 196.3 | 186.4-206.6 | 431.0 | 222.5 | 213.2-232.2 |
| I Leukemias, myeloproliferative and myelodysplastic diseases | 42.6 | 78.1 | 20.2 | 41.6 | 19.0 | 41.9 | 23.8 | 53.0 | 81.8 | 53.5 | 48.4-59.0 | 105.6 | 53.4 | 48.9-58.2 |
| I(a) Lymphoid leukemias | 29.0 | 53.2 | 16.0 | 33.0 | 10.8 | 23.8 | 13.2 | 29.4 | 55.8 | 36.5 | 32.3-41.1 | 69.0 | 34.7 | 31.1-38.6 |
| I(b) Acute myeloid leukemia | 6.4 | 11.7 | 1.8 | 3.7 | 3.8 | 8.4 | 6.8 | 15.1 | 12.0 | 7.9 | 6.0-10.1 | 18.8 | 9.7 | 7.8-11.9 |
| II Lymphomas and reticuloendothelial neoplasms | 10.6 | 19.4 | 12.2 | 25.1 | 17.6 | 38.8 | 31.6 | 70.3 | 40.4 | 27.9 | 24.2-32.1 | 72.0 | 38.6 | 34.7-42.8 |
| II(a) Hodgkin lymphoma | 0.4 | 0.7 | 1.4 | 2.9 | 6.2 | 13.7 | 16.6 | 37.0 | 8.0 | 5.9 | 4.2-8.0 | 24.6 | 13.7 | 11.4-16.3 |
| II(b,c,d) Non-Hodgkin lymphomas | 10.0 | 18.3 | 10.8 | 22.2 | 11.2 | 24.7 | 14.6 | 32.5 | 32.0 | 21.8 | 18.5-25.4 | 46.6 | 24.5 | 21.4-27.8 |
| III CNS & misc intracranial & intraspinal neoplasms | 23.4 | 42.9 | 17.2 | 35.4 | 16.8 | 37.1 | 9.4 | 20.9 | 57.4 | 38.4 | 34.1-43.2 | 66.8 | 34.0 | 30.5-37.9 |
| III(a) Ependymomas and choroid plexus tumor | 2.8 | 5.1 | 0.8 | 1.6 | 1.0 | 2.2 | 0.6 | 1.3 | 4.6 | 3.0 | 1.9-4.5 | 5.2 | 2.6 | 1.7-3.8 |
| III(b) Astrocytoma | 10.0 | 18.3 | 9.2 | 19.0 | 8.2 | 18.1 | 4.2 | 9.3 | 27.4 | 18.5 | 15.5-21.9 | 31.6 | 16.2 | 13.8-18.9 |
| III(c) Intracranial and intraspinal embryonal tumors | 5.4 | 9.9 | 3.2 | 6.6 | 2.2 | 4.9 | 1.4 | 3.1 | 10.8 | 7.0 | 5.3-9.2 | 12.2 | 6.1 | 4.6-7.8 |
| III(d) Other gliomas | 4.2 | 7.7 | 3.2 | 6.6 | 5.0 | 11.0 | 2.2 | 4.9 | 12.4 | 8.5 | 6.5-10.9 | 14.6 | 7.6 | 5.9-9.5 |
| IV Neuroblastoma and other peripheral nervous cell tumors | 18.4 | 33.7 | 3.6 | 7.4 | 0.4 | 0.9 | 1.0 | 2.2 | 22.4 | 13.5 | 11.1-16.3 | 23.4 | 10.7 | 8.8-12.8 |
| IV(a) Neuroblastoma and ganglioneuroblastoma | 18.4 | 33.7 | 3.6 | 7.4 | 0.4 | 0.9 | 0.6 | 1.3 | 22.4 | 13.5 | 11.1-16.3 | 23.0 | 10.5 | 8.6-12.6 |
| V Retinoblastoma | 9.2 | 16.9 | 0.4 | 0.8 | 0.2 | 0.4 | 0.0 | 0.0 | 9.8 | 5.7 | 4.2-7.6 | 9.8 | 4.3 | 3.2-5.7 |
| VI Renal tumors | 10.2 | 18.7 | 2.6 | 5.4 | 1.4 | 3.1 | 1.2 | 2.7 | 14.2 | 8.9 | 6.9-11.3 | 15.4 | 7.3 | 5.8-9.2 |
| VI(a) Nephroblastoma and other nonepithelial renal tumor | 10.2 | 18.7 | 2.4 | 4.9 | 0.6 | 1.3 | 0.0 | 0.0 | 13.2 | 8.2 | 6.3-10.4 | 13.2 | 6.1 | 4.7-7.8 |
| VII Hepatic tumors | 4.6 | 8.4 | 0.6 | 1.2 | 0.8 | 1.8 | 1.0 | 2.2 | 6.0 | 3.7 | 2.5-5.3 | 7.0 | 3.3 | 2.3-4.6 |
| VII(a) Hepatoblastoma and mesenchymal tumors of liver | 4.6 | 8.4 | 0.4 | 0.8 | 0.2 | 0.4 | 0.0 | 0.0 | 5.2 | 3.1 | 2.0-4.6 | 5.2 | 2.3 | 1.5-3.4 |
| VIII Malignant bone tumors | 1.4 | 2.6 | 4.4 | 9.1 | 9.4 | 20.7 | 8.8 | 19.6 | 15.2 | 11.0 | 8.6-13.7 | 24.0 | 13.1 | 10.9-15.7 |
| VIII(a) Osteosarcoma | 0.0 | 0.0 | 2.2 | 4.5 | 6.2 | 13.7 | 5.2 | 11.6 | 8.4 | 6.2 | 4.5-8.3 | 13.6 | 7.5 | 5.9-9.5 |
| VIII(c) Ewing tumor and related sarcomas of bone | 0.6 | 1.1 | 1.6 | 3.3 | 1.8 | 4.0 | 2.4 | 5.3 | 4.0 | 2.8 | 1.7-4.3 | 6.4 | 3.5 | 2.4-4.9 |
| IX Soft tissue and other extraosseous sarcomas | 8.4 | 15.4 | 5.2 | 10.7 | 9.0 | 19.9 | 8.8 | 19.6 | 22.6 | 15.3 | 12.6-18.4 | 31.4 | 16.4 | 13.9-19.2 |
| IX(a) Rhabdomyosarcoma | 5.4 | 9.9 | 2.2 | 4.5 | 1.8 | 4.0 | 1.6 | 3.6 | 9.4 | 6.1 | 4.4-8.1 | 11.0 | 5.4 | 4.1-7.1 |
| X Germ cell & trophoblastic tumors & gonadal neoplasms | 4.2 | 7.7 | 2.0 | 4.1 | 5.2 | 11.5 | 14.4 | 32.1 | 11.4 | 7.7 | 5.8-10.0 | 25.8 | 13.8 | 11.5-16.4 |
| X(a) Intracranial and intraspinal germ cell tumor | 0.6 | 1.1 | 0.4 | 0.8 | 1.8 | 4.0 | 1.0 | 2.2 | 2.8 | 2.0 | 1.1-3.3 | 3.8 | 2.0 | 1.2-3.2 |
| X(c) Malignant gonadal germ cell tumor | 1.2 | 2.2 | 1.2 | 2.5 | 3.4 | 7.5 | 10.0 | 22.3 | 5.8 | 4.1 | 2.7-5.9 | 15.8 | 8.7 | 6.9-10.8 |
| XI Other malignant epithelial neoplasms and malignant melanomas | 1.4 | 2.6 | 1.8 | 3.7 | 10.0 | 22.1 | 34.4 | 76.6 | 13.2 | 9.6 | 7.4-12.1 | 47.6 | 26.4 | 23.2-30.0 |
| XI(b) Thyroid carcinoma | 0.4 | 0.7 | 0.6 | 1.2 | 4.2 | 9.3 | 19.6 | 43.6 | 5.2 | 3.8 | 2.5-5.6 | 24.8 | 13.8 | 11.5-16.5 |
| XI(d) Malignant melanoma | 0.4 | 0.7 | 0.0 | 0.0 | 0.0 | 0.0 | 1.2 | 2.7 | 0.4 | 0.2 | 0.0-0.9 | 1.6 | 0.8 | 0.4-1.7 |
| XII Other and unspecified malignant neoplasms | 0.6 | 1.1 | 0.4 | 0.8 | 0.2 | 0.4 | 0.6 | 1.3 | 1.2 | 0.8 | 0.3-1.7 | 1.8 | 0.9 | 0.4-1.7 |
Notes
- Incidence data are provisional, November 2021.
- Rates are per 1,000,000 children. Rates for 0-14 and 0-19 year age intervals are age-adjusted within these intervals to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution.
- Non-Hodgkin lymphomas, Burkitt, and miscellaneous lymphomas are grouped together under II(b,c,d).
